Selected Content from Most Recent Issue of Pharma Marketing News

Toward Patient-Centric Marketing

Working Effectively with Patient Groups Patient groups and patients are invited to the table to debate regulatory issues, political policy issues and in some cases reimbursement issues as well. "So we have to take these people seriously," said Keith Allan, head of global ad-vocacy at Novartis, who discussed working with patient advocacy groups at the eyeforpharma Barcelona 2013 conference. "We have to involve them very early on in all our research programs, they need to be involved with us," he added. Putting in place a patient-centric marketing approach might prove a good strategy for a pharma company said Patrick J. Cashman, President and General Manager at Lundbeck Canada. He sais this during his keynote presentation titled "Lundbeck Adventures in Patient Centered Marketing" on the second day of the eyeforpharma Barcelona 2013 conference. This article is a summary of these two presentations. Topics include: Evolution of Patient Advocacy Characteristics of an "Ideal" Partnership Meeting Patient Advocates' Needs Declining Reputation The Corporate Reputation of Pharma - The Patient Perspective: Top Ten Pharma Performers Download the full text PDF file here: http://bit.ly/pmn120502pat

PHARMA MARKETING NEWS

www.pharmamarketingnews.com
Published by VirSci Corp.
PO Box 760
Newtown, PA 18940-0760

Each issue of Pharma Marketing News is packed with facts, opinions, and case studies based upon interviews with experts in the field of pharmaceutical marketing. Highlights of presentations from industry conferences and links to references help subscribers keep up to date on best practices and network with their peers.

Pharma Marketing News Email Addr: